NCT04803201 2026-04-02Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaAlliance for Clinical Trials in OncologyPhase 2 Suspended170 enrolled
NCT04668365 2025-04-25Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell LymphomaHenan Cancer HospitalPhase 2 Suspended59 enrolled